Vimarsana
Biggest News Aggregation in the World

Page 14 - Peter Kaiser News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Kaiser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Kaiser Today - Breaking & Trending Today

RHI Magnesita inaugurates new tunnel kiln of the "Digital Flagship Plant Radenthein" - Vimarsana News

RHI Magnesita inaugurates new tunnel kiln of the "Digital Flagship Plant Radenthein"

RHI Magnesita inaugurates new tunnel kiln of the "Digital Flagship Plant Radenthein"

IVERIC bio, Inc. (ISEE) Q1 2021 Earnings Call Transcript - Vimarsana News

IVERIC bio, Inc. (ISEE) Q1 2021 Earnings Call Transcript

Operator Good morning, and welcome to the Iveric Bio first-quarter 2021 earnings conference call. [Operator instructions] Please note this call is being recorded. I would now like to turn the conference over to Kathy Galante, senior vice president, investor relations. Please go ahead. Kathy Galante -- Senior Vice President, Investor Relations Good morning, and welcome to Iveric Bio's conference call. Representing Iveric Bio today are Glenn Sblendorio, chief executive officer; Pravin Dugel, president; David Carroll, chief financial officer; Dhaval Desai, chief development officer; Abraham Sca...

Source: fool.com
The Fifth Annual Retina Fellow Summit - Vimarsana News

The Fifth Annual Retina Fellow Summit

The Fifth Annual Retina Fellow Summit This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. 2.00 CME Activity Expiration Date: 12/31/2021 Activity Overview This activity features highlights captured from the Fifth Annual Retina Fellow Summit held in November 2020. The Summit included an expert faculty panel and an audience of retina fellows engaging in discussions on current clinical data, clinical cases, and practice transitions. The overall goal of this program is to provide retina fellows, ophthalmology residents, retina ...

Source: healio.com
Conbercept: New Generation of Product for Treatment of nAMD Completes 36-week Primary Endpoint Visits of Phase III Trial - Vimarsana News

Conbercept: New Generation of Product for Treatment of nAMD Completes 36-week Primary Endpoint Visits of Phase III Trial

Press release content from PR Newswire. The AP news staff was not involved in its creation. Conbercept: New Generation of Product for Treatment of nAMD Completes 36-week Primary Endpoint Visits of Phase III Trial December 23, 2020 GMT CHENGDU, China, Dec. 23, 2020 /PRNewswire/ -- Chengdu Kanghong Pharmaceutical Group (“Kanghong”) announced a key development milestone of its key product conbercept last month. Kanghong is seeking global approval of conbercept by undertaking a multicenter, multinational, double-masked, parallel-group, dose-ranging, active-controlled, randomized trial (nickna...

Source: apnews.com
Liechtenstein - A Good Thing in a Small Package - Vimarsana News

Liechtenstein - A Good Thing in a Small Package

Liechtenstein - A Good Thing in a Small Package December 18, 2020 A hiker’s paradise - that’s Liechtenstein.  It nestles cozily between Austria and Switzerland, a principality that, in 2006, celebrated 200 years of sovereignty.  It is one of the smallest countries in Europe, comprised of just 11 regions and 5,000 inhabitants.   I had long harbored a desire to visit this tiny country with its astonishing landscape of mountains, gorges, Alpine forests, crystal streams surging down craggy hillsides and peaceful valleys below.  Well, here I was and eager to get started ...